ETFS Holding Isis Pharmaceuticals

 
ETF Quotes for ETFS Holding Isis Pharmaceuticals top ^
  • Holdings: Qorvo Inc , Isis Pharmaceuticals , Graphic Packaging Holding Co , Brunswick Corp , Office Depot Inc ,
  • Morningstar Rating: 3 Stars
Sign-up for iwm investment picks
  • Holdings: Qorvo Inc , Isis Pharmaceuticals , Graphic Packaging Holding Co , Puma Biotechnology Inc , DexCom Inc ,
  • Morningstar Rating: 4 Stars
Sign-up for iwo investment picks
  • Holdings: Qorvo Inc , Isis Pharmaceuticals , Puma Biotechnology Inc , Graphic Packaging Holding Co , NPS Pharmaceuticals Inc ,
  • Morningstar Rating: 4 Stars
Sign-up for vtwg investment picks
  • Holdings: Qorvo Inc , Isis Pharmaceuticals , Brunswick Corp , Puma Biotechnology Inc , NPS Pharmaceuticals Inc ,
  • Morningstar Rating: 3 Stars
Sign-up for vtwo investment picks
  • Holdings: Alkermes PLC , Alaska Air Group Inc , Harman International Industries Inc , Isis Pharmaceuticals , Snap-on Inc ,
  • Morningstar Rating: 4 Stars
Sign-up for vb investment picks
  • Holdings: Alkermes PLC , Harman International Industries Inc , Isis Pharmaceuticals , Cooper Companies , Duke Realty Corp ,
  • Morningstar Rating: 4 Stars
Sign-up for vbk investment picks

 
Stock Quotes for Isis Pharmaceuticals top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
  • Morningstar Rating: 3 Stars
Sign-up for isis investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
  • Morningstar Rating: 3 Stars
Sign-up for isis investment picks

 
News Articles for Isis Pharmaceuticals top ^
2014/12/7
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin Data published in New England Journal of Medicine and featured at the American Society of Hematology annual meeting Isis to host a webcast at 9:00 a.m. ET on Monday, December 8, 2014 CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery investment picks
2014/12/5
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award investment picks
2015/1/6
Isis-owned Subsidiary Launched to Conduct Development and Commercialization of Isis' Lipid Franchise Drugs CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics investment picks
2015/1/5
Isis Strengthens Management Team Adding Strategic Business and Strategic Marketing Expertise CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer investment picks
2015/1/5
-- Collaboration Combines Isis' RNA-Targeted Technology With Expertise of Janssen in Autoimmune Disorders and Therapeutic Formulation --
Sign-up for Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract investment picks
2015/1/2
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2014/12/16
ISIS-DMPK Rx Extends the Targeting of Antisense Drugs to Include Muscle Tissue CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 investment picks
2015/1/8
Isis Pharmacueticals Inc. (ISIS) said Thursday it expects to "significantly" improve on its 2014 guidance, ending the year with a pro forma net operating loss in the mid to high teens and more than $725 million cash.
Sign-up for Isis Pharmaceuticals shares rise 2.8% after company raises outlook investment picks
2015/1/8
Strong Performance represents success of novel business strategy CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Significantly Improves Upon 2014 Financial Guidance investment picks
2015/1/14
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $7M for Advancing ISIS-SMN Rx in Children With Spinal Muscular Atrophy investment picks
2015/2/5
--Fourth Drug to Enter Development Under Broad Strategic Collaboration CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug Into Development to Treat a Neurodegenerative Disease investment picks
2015/2/4
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at Upcoming Investor Conferences investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Isis Pharmaceuticals
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Ishares US Technology  |  Next: Etfs Holding Istar Financial, Inc.